Abstract:
A sidespray for use with a water faucet unit includes a trigger valve and a volume control valve. The trigger valve is configured to define a full-ON water flow condition and a full-OFF water flow condition for the sidespray. A diverter actuator is coupled to the trigger valve to select between the full-ON water flow condition and the full-OFF water flow condition for the sidespray. The volume control valve is configured to define a volume-variable water passageway to limit a water flow volume through the sidespray when the trigger valve has set the sidespray to the full-ON water flow condition. A volume control actuator is coupled to the volume control valve to selectively adjust the water flow volume through the sidespray.
Abstract:
A compound of Formula (I) an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from: further wherein R1, R2, R3, R4, R5, R6, R7, and W are as described herein.
Abstract:
Embodiments herein provide a method that maintains computerized scripts. The scripts provide assistance to users with respect to using at least one computer software application that is operating on a computerized device. The method receives, from the user, at least one trigger. This process creates or “authors” the trigger. This “trigger” is an item that automatically initiates at least one of the scripts for the user. In addition, the method adds the trigger to the computer software application (not automatically, but instead based on user input). Thus, when initiated by the trigger, the script automatically outputs assistance (text, sounds, illustrations, educational videos, etc.) to the user through the computerized interface of the computerized device, so as to provide the needed assistance to the user.
Abstract:
A compound of Formula (I) an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from: further wherein R1, R2, R3, R4, R5, R6, R7, and W are as described herein.Also disclosed is a compound of Formula (II) an enantiomer, diastereomer, or a pharmaceutically-acceptable salt thereof, wherein each of G, X and Y are independently CH or N, wherein at each occurrence at least one of G, X or Y is N and the other two of G, X or Y are CH; and B is independently selected from: further wherein R1, R2, R3, R4, R5, R8, R9 and Z are as described herein.Also disclosed are pharmaceutical compositions containing compounds of Formula (I) and Formula (II), and methods of treating conditions associated with the activity of p38 kinase.
Abstract:
A compound of Formula (I) an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is as described herein. Also disclosed is a compound of Formula (II) an enantiomer, diastereomer, or a pharmaceutically-acceptable salt thereof, wherein each of G, X and Y are independently CH or N, wherein at each occurrence at least one of G, X or Y is N and the other two of G, X or Y are CH; and B, R1, R2, R3, R4, R5, R8, R9 and Z are as described herein. Also disclosed are pharmaceutical compositions containing compounds of Formula (I) and Formula (II), and methods of treating conditions associated with the activity of p38 kinase.
Abstract:
A method for automating variables in an end-user programming system is disclosed. The end-user programming system comprises a script, a shared repository, at least one database, a recorder, an interpreter, and an execution engine. The script comprises at least one command describing an event comprising a data value. Each user has a uniquely identified entry set for the entries distributed in at least one database. The interpreter automatically creates a variable for a data value in a command by comparing the data value with each entry value in the entry set for the user recording the command. The interpreter automatically instantiates a variable in a command with an entry value by comparing the variable with each entry name in the entry set for the user executing the command.
Abstract:
Compounds having the Formula (I), including pharmaceutically acceptable salts thereof, wherein at least one of X1, X2 or X3 is and any remaining X1, X2 or X3 is hydrogen, which are useful as kinase inhibitors, wherein R1, R2, R3, R4, R5, R6, A1, A2 and m are as described herein.
Abstract:
A method and system for dynamic creation of an OLAP cube is disclosed which enables OLAP cubes to be created from custom database entities and custom database entity relationships. A created cube may be implemented on a local or remote data server using a variety of modular database protocols. A computer-readable medium and system for OLAP cube data permission derivation is also disclosed. OLAP cube data permissions are derived from category data associated with an OLAP database. The resulting cube data permissions are associated with data in the OLAP cube.
Abstract:
A method and system for transforming XML documents to and from data objects in an object oriented framework includes: importing the XML document; parsing the XML document; building a DOM tree from the parsed XML document; constructing at least one DDO or at least one XDO based on the DOM tree; and storing the DDO or XDO in a datastore. The present invention provides a transformation bridge connecting the XML world and the object world, allowing conversions from XML documents to data objects and vice versa to be performed seamlessly. It enhances the existing framework with a feature to process XML documents utilizing the existing framework facilities. Application developers can thus exploit the key advantages of XML representation as well as object orientation.
Abstract:
The present invention provides a circuit for use in an ADPCM synthesizer for generating a function of a quantization step without the use of a look-up table. Illustratively, the function is represented in a piecewise linear fashion. This permits an ADPCM synthesizer to be implemented without the use of a memory storing a look-up table for the function so the area of the synthesizer chip can be reduced.